Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Trends of obesity and abdominal obesity in Tehranian adults: a cohort study

  • 1Email author,
  • 1,
  • 2,
  • 1 and
  • 3
BMC Public Health20099:426

https://doi.org/10.1186/1471-2458-9-426

©  Hosseinpanah et al; licensee BioMed Central Ltd. 2009

  • Received: 17 May 2009
  • Accepted: 23 November 2009
  • Published:
Open Peer Review reports

Abstract

Background

Considering the increasing trend of obesity reported in current data, this study was conducted to examine trends of obesity and abdominal obesity among Tehranian adults during a median follow-up of 6.6 years.

Methods

Height and weight of 4402 adults, aged 20 years and over, participants of the Tehran Lipid and Glucose Study (TLGS), were measured in 1999-2001(phase I) and again in 2002-2005(phase II) and 2006-2008 (phase III). Criteria used for obesity and abdominal obesity defined body mass index (BMI) ≥ 30 and waist circumference ≥ 94/80 cm for men/women respectively. Subjects were divided into10-year groups and the prevalence of obesity was compared across sex and age groups.

Results

The prevalence of obesity was 15.8, 18.6 and 21% in men and 31.5, 37.7 and 38.6% in women in phases I, II and III respectively (p < 0.001). The prevalence of abdominal obesity in men was 36.5, 57.2 and 63.3% and in women was 76.7, 83.8 and 83.6% in the three periods mentioned (p < 0.001). Men aged between 20-29 years had highest increase rates of obesity and abdominal obesity in phase III in comparison with phase I (with a respective rates of 2.2- and 3.3-fold). In both sexes, an increased trend was observed between phases I and II, whereas between phases II and III, this trend was observed in men, but not in women.

Conclusion

This study demonstrates alarming rises in the prevalences of both obesity and abdominal obesity in both sexes especially in young men, calling for urgent action to educate people in lifestyle modifications.

Keywords

  • Body Mass Index
  • Obesity
  • Waist Circumference
  • Physical Activity Level
  • Abdominal Obesity

Background

Obesity, general and abdominal, poses one of the greatest public health challenges for the 21st century with particularly alarming trends in several parts of the world [1]. Unhealthy diets and physical inactivity are the main contributors to overweight and obesity, which are among the leading risk factors for the major non-communicable diseases. The most significant consequences for health of overweight and obesity include hypertension and hyperlipidaemia, coronary heart diseases, ischemic stroke, type 2 diabetes, certain kinds of cancer [2]. In 2005, the estimated total numbers of overweight and obese adults worldwide, were 937 million and 396 million respectively [1], numbers that have doubled in comparison to 20 years ago [3]; by 2030, these figures are projected to be 1.3 billion and 573 million for overweight and obese adults respectively [1]. Recently there is a greater emphasis on abdominal obesity, as compared with general obesity, in relation to the risk of incidence of non-communicable weigh-related diseases [4]. Studies show the prevalence of abdominal obesity to be increasing along with general obesity [5]; for instance, in NHANES, during 10 years (from 1994 to 2004), an increase of 10% was observed in the prevalence of abdominal obesity among American adults [6].

In Iran, the prevalence of overweight and obesity in 2005 was reported to be 42.8% in men and 57% in women [7]; for 2015, the figures are predicted to be 54 and 74% respectively [8]. Studies have shown that the prevalence of abdominal obesity to range between 9.7 - 12.9% and 54.5 - 63.7% in Iranian men and women respectively [7, 9]. There is however limited data available on this trend from Iran.

The Tehran Lipid and Glucose Study (TLGS) with median follow-up of 3.6 years [10] reported an increasing trend for prevalence of obesity and abdominal obesity in both sexes. We conducted this survey with the objective of determining this trend in Tehranian adults between the years 1999 and 2008 (with median follow-up of 6.6 years).

Methods

General information

The Tehran Lipid and Glucose Study was conducted to determine the risk factors of atherosclerosis among Tehran's urban population and to develop population-based measures to prevent the rising trend of diabetes mellitus and dyslipidemia. The design of this study encompasses three major components; phase I, a cross-sectional prevalence study of cardiovascular disease and associated risk factors and phases II and III, prospective follow-ups study for 20 years [11]. A multistage stratified cluster random sampling technique was used to select 15,005 people, aged 3 years or older, from district 13 of Tehran, the capital of the Iran; the district is located in the center of Tehran and the age distribution of its population is representative of the overall population of Tehran. From this population, only individuals above 20 years old, who participated in phase I in 1999-2001, phase II in 2002-2005 and phase III in 2006-2008 were chose. The interval between two assessments was at approximately 3.6-year intervals in this survey. The details of this study have been published elsewhere [12].

Data collection

After excluding subjects aged < 20 years (n = 4637), those with missed values of weight, height, or other variables (n = 485), or lost to follow-up (n = 5481), data of 4402 subjects including 41.6% men (1835 persons) with a complete 6.6-year follow-up was used in this cohort study. There were 708 subjects in the 20-29 years age group, 1088 aged 30-39 years, 983 aged 40-49 years, 828 aged 50-59 years, 655 between 60 and 69 years, and 140 aged 70 years and over. In comparison to those who completed the follow-up, individuals lost to follow-up had lower value of systolic blood pressure (119 vs. 117 mmHg), fasting plasma glucose (4.99 vs. 4.94 mmol/L), age (44.5 vs. 41.5 years), BMI (27.1 vs. 26.5 Kg/m2) and waist circumference (89.1 vs. 87.2 cm) (p < 0.001).

This study was approved by the Research Ethics Committee of the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, and informed written consent was obtained from all subjects and was conducted in accordance with the principles of the Declaration of Helsinki.

Anthropometric measures

Weight and height were determined using a digital electronic weighing scale (Seca 707; range 0.1-150 kg, Hanover, MD) with an accuracy of up to 100 gr (the machine was regularly checked for precision after every 10 measurements) and tape meter stadiometer respectively. Waist and hip circumferences were measured using standard protocols by a trained individual. Waist circumference was measured at the level of the umbilicus and hip circumference was measured over light clothing at the widest girth of the hip. Body mass index [BMI = weight (kg)/height2 (m2)] and waist-to-hip ratio [WHR = waist circumference (cm)/hip circumference (cm)] were calculated; according to the International Obesity Task Force (IOTF) guidelines, overweight was determined as BMI > 25 and < 30, obesity was defined as BMI ≥ 30 [13], WC ≥ 94 cm in men and ≥ 80 cm in women was considered as the cut-offs for determining abdominal obesity [14].

Statistical analysis

All variables are expressed as mean (SE) or percent. The means between 3 phases were compared using the repeated measurement test and comparison of overweight, obesity and abdominal obesity percentage between 3 phases was done using the Cochran test. Bonferroni correction was used for multiply comparison between these phases. In each phase, logistic models were developed to evaluate the role of sex in prediction of overweight, obesity and abdominal obesity separately. Age adjusted prevalence was estimated with the reference population group of Tehran according to the data from the 2006 census. All analyses were stratified by sex. All tests for statistical significance were two-tailed and performed assuming a type I error probability of < 0.05. All data were analyzed by the SPSS soft ware package (SPSS for Windows; SPSS Inc., Chicago, IL, USA; Version 16.00).

Results

The mean ages of subjects in the 3 phases were 44.5, 48 and 50.9 years respectively. Of 4402 study participants, of 58.4% (n = 2567) were women. Mean Body Mass Index (BMI) was 27.1, 27.9 and 28.2 Kg/m2 in phase I, II and III, respectively; and mean WC was 89.1, 93.3 and 93.9 cm, respectively.

Mean (SE) for BMI, WC and WHR increased significantly in all age groups, in both sexes, between phase I and III. Whereas in men, WC increased in all age groups between the mentioned phases, increases for women were observed only between phases I and II (Table 1).
Table 1

Mean (SE) of BMI, WC and WHR in three phases of TLGS.

Age group

(years)

Number

BMI(kg/m2)

WC (cm)

WHR

  

Phase I

Phase II

Phase III

Phase I

Phase II

Phase III

Phase I

Phase II

Phase III

Men

          

20-29

266

24.6 (0.3)

26.0 (0.3)

27.1 (0.3)*

83.0 (0.8)

91.0 (0.8)

95.0 (0.7)*

0.86 (0.00)

0.91 (0.00)

0.94 (0.00)*

30-39

459

26.2 (0.2)

27.0 (0.2)

27.6 (0.2)*

88.3 (0.5)

94.4 (0.5)

96.2 (0.5)*

0.90 (0.00)

0.93 (0.00)

0.96 (0.00)*

40-49

369

26.6 (0.2)

27.2 (0.2)

27.4 (0.2)*

90.8 (0.5)

95.7 (0.5)

97.0 (0.5)*

0.93 (0.00)

0.95 (0.00)

0.97 (0.00)*

50-59

319

26.5 (0.2)

26.8 (0.2)

26.4 (0.2)*

92.1 (0.6)

96.2 (0.6)

97.4 (0.5)*

0.95 (0.00)

0.97 (0.00)

0.99 (0.00)*

60-69

328

26.5 (0.2)

26.7 (0.2)

26.5 (0.2)†

93.0 (0.6)

97.1 (0.6)

97.7 (0.6)*

0.95 (0.00)

0.98 (0.00)

1.00 (0.00)*

≥ 70

94

25.4 (0.4)

25.7 (0.4)

25.5 (0.4)

90.7 (1.0)

94.9 (1.0)

95.7 (0.9)*

0.95 (0.00)

0.98 (0.00)

0.99 (0.00)*

Total

1835

26.1 (0.1)

26.7 (0.1)

27.1(0.1)*

89.6 (0.3)

95.0 (0.2)

96.6 (0.2)*

0.92 (0.00)

0.95 (0.00)

0.97 (0.00)*

Women

          

20-29

442

24.4 (0.2)

25.8 (0.2)

26.4 (0.2)*

78.0 (0.5)

81.5 (0.5)

81.4 (0.5)*

0.77 (0.00)

0.80 (0.00)

0.80 (0.00)*

30-39

629

27.2 (0.2)

28.5 (0.2)

28.7 (0.2)*

85.2 (0.4)

89.1 (0.4)

88.7 (0.5) *

0.81 (0.00)

0.84 (0.00)

0.84 (0.00)*

40-49

614

29.2 (0.2)

30.1 (0.2)

30.4 (0.2)*

91.5 (0.5)

95.0 (0.4)

95.0 (0.4)*

0.85 (0.00)

0.88 (0.00)

0.88 (0.00)*

50-59

509

29.6 (0.2)

30.2 (0.2)

30.5 (0.2)*

94.4 (0.5)

97.8 (0.5)

97.7 (0.5)*

0.88 (0.00)

0.91 (0.00)

0.91 (0.00)*

60-69

327

28.8 (0.2)

29.4 (0.2)

29.3 (0.2)*

95.0 (0.6)

98.0 (0.6)

97.2 (0.6)*

0.91 (0.00)

0.93 (0.00)

0.93 (0.00)*

≥ 70

46

27.0 (0.6)

27.4 (0.6)

27.4 (0.6)†

92.7 (1.7)

95.0 (1.6)

94.3 (1.8)

0.91 (0.01)

0.94 (0.01)

0.94 (0.01)*

Total

2567

27.9 (0.1)

28.9 (0.1)

29.1 (0.1)*

88.7 (0.2)

92.2 (0.2)

91.9 (0.3)*

0.84 (0.00)

0.87 (0.00)

0.87 (0.00)*

SE: Standard Error, BMI: Body Mass Index, WC: Waist Circumference, WHR: Waist to Hip Ratio, TLGS: Tehran Lipid and Glucose Study,

* p < 0.001; † p < 0.01 as compared to values in Phase I.

Sex-specific prevalences of overweight, obesity and abdominal obesity

Overall prevalence of overweight, obesity and abdominal obesity in both sexes are showed in Table 2; while age adjusted prevalence of overweight, obesity and abdominal obesity in baseline were 55.4, 14.4 and 303% in men and 64.5, 22.9 and 68% in women, respectively. Percentages of overweight, obesity and abdominal obesity have risen significantly in both sexes through three phases mentioned, (p < 0.001) (Table 2). In phase III, The highest prevalence of overweight and abdominal obesity was found in the 40-49 and 60-69 year-old groups of both sexes, respectively. The maximum prevalence of obesity was seen in 30-39-year-old men and 50-59-year old women. Although a higher prevalence of abdominal obesity was seen in women (p < 0.001), a slight decrease was observed in phase III.
Table 2

The prevalences of Overweight, Obesity and Abdominal obesity in three phases of TLGS.

Age group (years)

Number

Overweight, %

Obesity, %

Abdominal obesity, %

  

Phase I

Phase II

Phase III

Phase I

Phase II

Phase III

Phase I

Phase II

Phase III

Men

          

20-29

266

40.6

55.3

67.3*

10.5

17.6

22.9*

16.1

38.7

53.7*

30-39

459

59.9

69.0

74.3*

15.9

30.7

24.6*

32.6

54.6

61.4*

40-49

369

67.5

74.6

75.1*

15.2

50.3

22.77*

37.6

61.5

65.0*

50-59

319

66.8

69.0

70.8

20.7

47.9

19.7

45.7

62.3

67. 7*

60-69

328

66.8

66.5

66.5

16.8

41.8

16.5

48.4

66.4

69.2*

≥ 70

94

52.1

54.2

48.9

13.8

19.6

12.8

35.1

55.3

57.4*

Total

1835

60.6

66.9

70.1

15.8

37.8

21.1*

36.5

57.2

63.3*

Women

          

20-29

442

41.8

55.7

59.0*

11.8

17.6

18.1*

43.8

54.9

55.2*

30-39

629

69.3

78.3

80.9*

23.2

30.7

33.7*

68.9

80.2

79.8*

40-49

614

82.7

88.3

89.6*

40.4

50.3

49.0*

86.3

92.1

92.5*

50-59

509

84.3

88.2

88.6*

44.4

47.9

52.0*

91.9

94.6

93.9†

60-69

327

81.6

83.1

82.9

38.2

41.8

40.9

92.3

95.7

95.4†

≥ 70

46

73.9

78.3

73.9

17.4

19.6

26.7

89.1

93.4

89.1

Total

2567

72.4

79.4

80.9*

31.3

37.8

38.6*

76.7

83.8

83.6*

TLGS: Tehran Lipid and Glucose Study, Overweight: BMI = 24.9-29.9, Obesity: BMI ≥ 30, Abdominal obesity: WC ≥ 94/80 cm for men/women respectively, * p < 0.001, † p < 0.01 as compared to values in Phase I

Changes in BMI, WC and WHR in both sexes

The trends of changes in BMI, WC and WHR from phase I to II showed increases in both sexes, significantly more so in women. Among men, this trend increased from phase II to III, while in women it was relatively stable (Figure 1A, B, C). Trends of overweight, obesity and abdominal obesity in women increased from phases I to III, the rate decreasing between phases II and III in women, but not so in men (Figure 1D, E, F).
Figure 1
Figure 1

Median 6.6-years changes in BMI(A), WC(B), WHR(C), and prevalences of overweight(D), obesity(E) and abdominal obesity(F). BMI: Body Mass Index, WC: Waist circumference, WHR: Waist to Hip Ratio, Overweight: BMI = 24.9-29.9, Obesity: BMI ≥ 30, Abdominal obesity: WC ≥ 94/80 cm for men/women respectively * p < 0.001 as compared to values in Phase I.

Figure 2 shows relative changes in BMI, WC, overweight, obesity and abdominal obesity in the different age groups of men and women. Among both sexes, the highest rise in BMI was observed among 20-29 year-olds, with a smaller peak being observed among 30-39-years-olds. In men, changes in WC were substantially larger between phases I and II than between II and III, a trend not observed in women (Figure 2A, B). Men showed a greater change in prevalence of overweight, obesity and abdominal obesity, particularly in the youngest age group (20-29 years) (Figure 2C, D, E).
Figure 2
Figure 2

Median 6.6-years, age-group specific changes in BMI(A), WC(B) and the prevalences of overweight(C), obesity(D) and abdominal obesity(E). BMI: Body Mass Index, WC: Waist circumference, Overweight: BMI = 24.9-29.9, Obesity: BMI ≥ 30, Abdominal obesity: WC ≥ 94/80 cm for men/women respectively.

An association was observed between female gender and overweight, obesity and abdominal obesity in all 3 phases, but the strength of this association decreased between phase II and III (p < 0.001) (Table 3).
Table 3

The OR(95% CI) of overweight, obesity and abdominal obesity in women(n = 2567) compared to men(n = 1835) in three phases.

 

Odds ratio (95% CI)

 

Phase I

Phase II

Phase III

Overweight:

   

   Men

1.0

1.0

1.0

   Women

1.7 (1.5-1.9)

1.9 (1.7-2.2)

1.8 (1.6-2.0)

Obesity:

   

   Men

1.0

1.0

1.0

   Women

2.4 (2.0-2.8)

2.6 (2.3-3.0)

2.3 (2-2.6)

Abdominal Obesity:

   

   Men

1.0

1.0

1.0

   Women

5.7(5.0-6.5)

3.9(3.4-4.4)

2.9(2.5-3.4)

OR: odds ratio, CI: confidence interval, Overweight: BMI = 24.9-29.9, Obesity: BMI ≥ 30, Abdominal obesity: WC ≥ 94/80 cm for men/women respectively.

Discussion

The results of this study show an increasing trend of obesity and abdominal obesity in the urban adult Tehranian population over 6.6 years. The prevalence of obesity increased 33 and 23% in men and women respectively; abdominal obesity during this period, showed increase of 71% in men and 9% in women. Thus, the increasing trend of abdominal obesity was dramatically higher in men than in women; also at the end of follow up the prevalences of abdominal obesity in men and women were 63 and 84%, respectively.

This high increase in the prevalence of obesity and abdominal obesity may be due to changes in lifestyle and shifts in nutritional patterns in Iran, [15] attributable to industrialization and substitution of high-fat, refined carbohydrate, and low-fiber diets [16]. The shift in the frameworks of occupations, transportation systems and the nature of activities related to occupations and leisure both in Iran [17] and worldwide, [18] has led to lower levels of physical activity, a main contributor to the increasing trend in obesity and abdominal obesity. In addition, we found that the distribution of prevalence of obesity did not change much, and a remarkable shift towards higher prevalence of abdominal obesity was observed. These findings are in agreement with literature available from USA [6] and Finland [19]. Explanations for the upward trend in abdominal obesity in comparison with fewer changes in obesity may be related to the changes in health behaviour over time. Several studies have shown lifestyle factors to be associated with body fat distribution [19], for example a decrease in physical activity level, increased smokers and changes in trans fat and fiber consumption [20].

Recent studies show the trend of obesity and abdominal obesity to be increasing, in both developed and developing countries [18, 19, 21]. This trend rose from 12 to 23% in USA over 15 years [22] and from 43 to 52% in Jordan over 10 years [23], as a developing country. Our findings indicate that the prevalence of Tehranian obese adults is increased from 25 to 31% during 6.6 years; the difference may be due to varying cultures of societies, the socio-economic status of populations and design and sample size of studies. Although the trend of abdominal obesity is seen to be increasing in all studies, describing and comparing the prevalence of abdominal obesity in different populations is somewhat problematic because different cut points have been use in different studies.

In agreement with other studies worldwide[1, 24] and in Iran [7, 9, 25], our findings show that the prevalences of obesity and abdominal obesity in women are higher than men; gender differences in food intake, physical activity level and psycho-socio-economic status may be responsible for this difference. For example, results of a survey showed that Tehranian women consume more sweets and simple sugars [26]. In addition, lower physical activity levels among women, several pregnancies, lower socio-economic status, unemployment in many Tehranian women, a higher ratio of depression, and lower education level may be some of the reasons for the susceptibility of women to obesity as compared to men [17]. In contrast of our results, the prevalence of obesity in Kuwait [27] and abdominal obesity in Palestin among women was lower than men [28]; which can be due to differences in cultures of the Arab and Iranian populations.

In this study, we provide evidence that the trends of obesity and abdominal obesity are more alarming in men than in women, which can be due to the importance given by women to their health, because of their increasing educational levels and more income in recent years. It can also be a result of public educational programs being focused more on women as the target group because of their higher obesity levels compared to men. Moreover ignoring men in implemented public educational programs, causes the trend of obesity got worse among them compared to women during recent years. Our findings are consistent with recently published studies from Sweden [29, 30], England [31] and Greece [32], showing the upward trends both in general and abdominal obesity among men (especially in the youngest group), compared to these levels remaining stable among women during recent years.

Regarding both the strengths and limitations of our study, the main strength of our study is first large population-based study with 6.6 years follow up of a same population in Iran, and the Middle East Region. The main limitation of our analyses, a considerable fraction of subjects (about fifty percent) was lost during the follow-up period due to immigration. Considering that those who lost to follow up had lower BMI and WC compared to those who completed study, we may have overestimated the reported trend in overweight, obesity and abdominal obesity in this population.

Conclusion

In conclusion, an alarming increase was shown in the prevalences of overweight, obesity and abdominal obesity among in both sexes of Tehranian adults, the highest trend being observed in the 20-29 year age groups, especially in men. There is the urgent need to target younger ages for prevention and implementation of public educational programs to curtail this rising trend in obesity and abdominal obesity especially in young men.

Declarations

Acknowledgements

We would like to thank the staff and participants in the TLGS study for their important contribution, Marjan Afghan for preparation of tables and figures, and Mr. Mehdi Mojarrad for reference. We nearby acknowledge Mrs. Nilufar Shiva for her assistance in manuscript preparation and language editing.

Authors’ Affiliations

(1)
Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
(2)
Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
(3)
Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

References

  1. Kelly T, Yang W, Chen CS, Reynolds K, He J: Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008, 32: 1431-1437. 10.1038/ijo.2008.102.View ArticleGoogle Scholar
  2. World Health Organization: Obesity: Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000, 894: i-xii. 1-253.Google Scholar
  3. James PT, Rigby N, Leach R: International Obesity Task Force. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil. 2004, 11: 3-8. 10.1097/01.hjr.0000114707.27531.48.View ArticlePubMedGoogle Scholar
  4. Panagiotakos DB, Pitsavos C, Skoumas Y, Lentzas Y, Papadimitriou L, Chrysohoou C, Stefanadis C: Abdominal obesity, blood glucose and apolipoprotein B levels are the best predictors of the incidence of hypercholesterolemia(2001-2006) among healthy adults: ATTICA Study. Lipids in Health and disease. 2008, 7: 11-10.1186/1476-511X-7-11.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Hirani V, Zaninotto P, Primatesta P: Generalized and abdominal obesity and risk of diabetes, hypertension and hypertension-diabetes co-morbidity in England. Public Health Nutr. 2008, 11: 521-527. 10.1017/S1368980007000845.View ArticlePubMedGoogle Scholar
  6. Ford ES, Zhao G, Li C, Pearson WS, Mokdad AH: Trends in obesity and abdominal obesity among hypertensive and non hypertensive adults in the United States. Am J Hypertens. 2008, 21: 1124-1128. 10.1038/ajh.2008.246.View ArticlePubMedGoogle Scholar
  7. Janghorbani M, Amini M, Willett WC, Mehdi Gouya M, Delavari A, Alikhani S, Mahdavi A: First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity (Silver Spring). 2007, 15: 2797-2808. 10.1038/oby.2007.332.View ArticleGoogle Scholar
  8. World Health Organization: Chronic deaseases are the major cause of death and disability worldwide. [Cited 2008 Aug 12]., [http://www.who.int/chp/chronic_disease_report/media/Factsheet1.pdf]
  9. Kelishadi R, Alikhani S, Delavari A, Alaedini F, Safaie A, Hojatzadeh E: Obesity and associated lifestyle behaviours in Iran: findings from the First National Non-communicable Disease Risk Factor Surveillance Survey. Public Health Nutr. 2008, 11: 246-251. 10.1017/S1368980007000262.View ArticlePubMedGoogle Scholar
  10. Azizi F, Azadbakht L, Mirmiran P: Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998-1999 and 2001- Tehran lipid and glucose study. Ann Nutr Metab. 2002, 49: 3-8. 10.1159/000084171.View ArticleGoogle Scholar
  11. Azizi F, Rahmani M, Emami H, Madjid M: Tehran Lipid and Glucose Study: Rational and design. CVD Prevention. 2000, 3: 424-427.Google Scholar
  12. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S, the Tehran Lipid and Glucose Study Group: Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009, 10: 5-View ArticlePubMedPubMed CentralGoogle Scholar
  13. Tsigos C, Hainer V, Basdevant A, Finer N, Fried M, Mathus-Vliegen E, Micic D, Maislos M, Roman G, Schutz Y, Toplak H, Zahorska-Markiewicz B, for the Obesity Management Task Force of the European Association for the Study of Obesity: Management of Obesity in Adults: European Clinical Practice Guidelines. Obesity Facts. 2008, 1: 106-116. 10.1159/000126822.View ArticlePubMedGoogle Scholar
  14. Alberti KG, Zimmet P, Shaw J: Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006, 23: 469-480. 10.1111/j.1464-5491.2006.01858.x.View ArticlePubMedGoogle Scholar
  15. Esmaillzadeh A, Azadbakht L: Major dietary patterns in relation to general obesity and central adiposity among Iranian women. J Nutr. 2008, 138: 358-363.PubMedGoogle Scholar
  16. Mirmiran P, Mohammadi F, Allahverdian S, Azizi F: Estimation of energy requirements for adults: Tehran lipid and glucose study. Int J Vitam Nutr Res. 2003, 73: 193-200. 10.1024/0300-9831.73.3.193.View ArticlePubMedGoogle Scholar
  17. World Health Organization: Global strategy on diet, physical activity and health: obesity and overweight. Geneva: World Health Organization; 2003 (WHO fact sheet)Google Scholar
  18. Torrance GM, Hooper MD, Reeder BA: Trends in overweight and obesity among adults in Canada (1970-1992): Evidence from national surveys using measured height and weight. Int J Obes. 2002, 26: 797-804. 10.1038/sj.ijo.0801991.View ArticleGoogle Scholar
  19. Lahti-Koski M, Harald K, Männistö S, Laatikainen T, Jousilahti P: Fifteen-year changes in body mass index and waist circumference in Finnish adults. Eur J Cardiovasc Prev Rehabil. 2007, 14: 398-404. 10.1097/HJR.0b013e32800fef1f.View ArticlePubMedGoogle Scholar
  20. Koh-Banerjee P, Chu NF, Spiegelman D, Rosner B, Colditz G, Willett W, Rimm E: Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16 587 US men. Am J Clin Nutr. 2003, 78: 719-727.PubMedGoogle Scholar
  21. Mayer-Davis EJ, Kirkner GJ, Karter AJ, Zaccaro DJ: Metabolic predictors of 5-year change in weight and waist circumference in a triethnic population: the insulin resistance atherosclerosis study. Am J Epidemiol. 2003, 157: 592-601. 10.1093/aje/kwg022.View ArticlePubMedGoogle Scholar
  22. Menifield CE, Doty N, Fletcher A: Obesity in America. ABNF J. 2008, 19: 83-88.PubMedGoogle Scholar
  23. Khader Y, Batieha A, Ajlouni H, El-Khateeb M, Ajlouni K: Obesity in Jordan: prevalence, associated factors, comorbidities, and change in prevalence over ten years. Metab Syndr Relat Disord. 2008, 6: 113-120. 10.1089/met.2007.0030.View ArticlePubMedGoogle Scholar
  24. Berghöfer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN: Obesity prevalence from a European perspective: a systematic review. BMC Public Health. 2008, 8: 200-210. 10.1186/1471-2458-8-200.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Malekzadeh R, Mohamadnejad M, Merat Sh, Pourshams A, Etemadi A: Obesity pandemic: an Iranian perspective. Archives of Iranian Medicine. 2005, 8: 1-7.Google Scholar
  26. Mirmiran P, Mohammadi F, Sarbazi N, Allahverdian S, Azizi F: Gender differences in dietary intakes, anthropometrical measurements and biochemical indices in an urban adult population: Tehran Lipid and Glucose Study. Nutr Metab Cardiovasc Dis. 2003, 13: 64-71. 10.1016/S0939-4753(03)80020-0.View ArticlePubMedGoogle Scholar
  27. Al-Isa AN: Changes in body mass index (BMI) and prevalence of obesity among Kuwaitis 1980-1994. Int J Obes Relat Metab Disord. 1997, 21: 1093-1099. 10.1038/sj.ijo.0800505.View ArticlePubMedGoogle Scholar
  28. Abdul-Rahim HF, Abu-Rmeileh NM, Husseini A, Holmboe-Ottesen G, Jervell J, Bjertness E: Obesity and selected co-morbidities in an urban Palestinian population. Int J Obes Relat Metab Disord. 2001, 25: 1736-1740. 10.1038/sj.ijo.0801799.View ArticlePubMedGoogle Scholar
  29. Lilja M, Eliasson M, Stegmayr B, Olsson T, Söderberg S: Trends in obesity and its distribution: data from the Northern Sweden MONICA Survey, 1986-2004. Obesity (Silver Spring). 2008, 16: 1120-1128.Google Scholar
  30. Faeh D, Marques-Vidal P, Chiolero A, Bopp M: Obesity in Switzerland: do estimates depend on how body mass index has been assessed?. Swiss Med Wkly. 2008, 138: 204-210.PubMedGoogle Scholar
  31. Bose K: Age trends in adiposity and central body fat distribution among adult white men resident in Peterborough, East Anglia, England. Coll Antropol. 2002, 26: 179-186.PubMedGoogle Scholar
  32. Papadimitriou A, Fytanidis G, Papadimitriou DT, Priftis KN, Nicolaidou P, Fretzayas A: Prevalence of overweight and obesity in young Greek men. Obes Rev. 2008, 9: 100-10.1111/j.1467-789X.2007.00420.x.View ArticlePubMedGoogle Scholar

    33. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/9/426/prepub

Copyright

© Hosseinpanah et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

BMC Public Health

ISSN: 1471-2458

Contact us